Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Pain Therapeutics, Inc.    

PAIN THERAPEUTICS, INC.

SummaryChartsNewsCalendarCompany 
 News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news
Most relevant news about PAIN THERAPEUTICS, INC.
09/17CASSAVA SCIENCES : Initiates Phase 2b Clinical Study in Alzheimer's Patients
AQ
09/16Cassava Sciences Initiates Phase 2b Clinical Study in Alzheimer's Patients
GL
09/09Cassava Sciences Reports Positive Phase 2a Clinical Results in Alzheimer's Pa..
GL
09/03Cassava Sciences to Present at H.C. Wainwright's 21st Annual Global Investmen..
GL
08/12Cassava Sciences Announces Second Quarter 2019 Financial Results
GL
06/19CASSAVA SCIENCES : to Present at Maxim Group's Conference on Alzheimer's disease
AQ
06/18Cassava Sciences to Present at Maxim Group's Conference on Alzheimer's Diseas..
GL
05/28CASSAVA SCIENCES : Announces New Website Launch
AQ
04/29Cassava Sciences Reports First Quarter 2019 Financial Results
GL
04/15Cassava Sciences Completes Patient Enrollment for a Phase 2a Study in Patien..
GL
03/28PAIN THERAPEUTICS : Announces Name Change to Cassava Sciences, Inc
AQ
03/27Pain Therapeutics Announces Name Change to Cassava Sciences, Inc.
GL
03/25Pain Therapeutics Reports 2018 Financial Results and Corporate Update
GL
03/08PAIN THERAPEUTICS : Co-Chairs Centrexion Therapeutics & Metys Pharmaceuticals Se..
AQ
02/05PAIN THERAPEUTICS : Announces Feedback from Recent Meeting with FDA on REMOXY
PU
More most relevant news
All news about PAIN THERAPEUTICS, INC.
09/17CASSAVA SCIENCES : Initiates Phase 2b Clinical Study in Alzheimer's Patients
AQ
09/16Cassava Sciences Initiates Phase 2b Clinical Study in Alzheimer's Patients
GL
09/09CASSAVA SCIENCES INC : Other Events (form 8-K)
AQ
09/09Cassava Sciences Reports Positive Phase 2a Clinical Results in Alzheimer's Pa..
GL
09/03Cassava Sciences to Present at H.C. Wainwright's 21st Annual Global Investmen..
GL
08/12CASSAVA SCIENCES : Management's Discussion and Analysis of Financial Condition a..
AQ
08/12CASSAVA SCIENCES INC : Results of Operations and Financial Condition (form 8-K)
AQ
08/12Cassava Sciences Announces Second Quarter 2019 Financial Results
GL
06/19CASSAVA SCIENCES : to Present at Maxim Group's Conference on Alzheimer's disease
AQ
06/19CASSAVA SCIENCES : to Present at Maxim Groups Conference on Alzheimers Disease
AQ
More news
News in other languages on PAIN THERAPEUTICS, INC.
2017PAIN THERAPEUTICS, INC. : REVERSE SPLIT: 1 of 7
Press releases
09/17CASSAVA SCIENCES : Initiates Phase 2b Clinical Study in Alzheimer's Patients
AQ
09/16Cassava Sciences Initiates Phase 2b Clinical Study in Alzheimer's Patients
GL
09/09CASSAVA SCIENCES INC : Other Events (form 8-K)
AQ
09/09Cassava Sciences Reports Positive Phase 2a Clinical Results in Alzheimer's Pa..
GL
09/03Cassava Sciences to Present at H.C. Wainwright's 21st Annual Global Investmen..
GL
More press releases
Sector news : Bio Therapeutic Drugs
10/18GRAPHIC - TAKE FIVE : Super Saturday, Super Mario
RE
10/18TODAY'S LOGISTICS REPORT : Fred Smith's Growing FedEx Challenge; Seeking Rail Vo..
DJ
10/18JOHNSON & JOHNSON : Genmab, Janssen Get CHMP Positive Option for Expanded Darzal..
DJ
10/18SNAKES AND LADDERS : SoftBank Vision Fund's climbing, sliding valuations
RE
10/18European Businesses Give Draft Deal Cautious Welcome -- WSJ
DJ
More sector news : Bio Therapeutic Drugs
Upcoming event on PAIN THERAPEUTICS, INC.